IL261622B2 - Use of dental pulp stem cells expressing mesenchymal and neuronal markers and the compounds containing them in the treatment of neurological diseases - Google Patents

Info

Publication number

IL261622B2

IL261622B2 IL261622A IL26162218A IL261622B2 IL 261622 B2 IL261622 B2 IL 261622B2 IL 261622 A IL261622 A IL 261622A IL 26162218 A IL26162218 A IL 26162218A IL 261622 B2 IL261622 B2 IL 261622B2

Authority

IL

Israel

Prior art keywords

cells

pharmaceutical composition

hidpscs

stem cells

hidpsc

Prior art date

2016-03-09

Links

• Espacenet
• Global Dossier
• Discuss

• 230000001537 neural effect Effects 0.000 title claims description 48
• 208000012902 Nervous system disease Diseases 0.000 title claims description 38
• 208000025966 Neurological disease Diseases 0.000 title claims description 38
• 210000005258 dental pulp stem cell Anatomy 0.000 title claims description 24
• 239000000203 mixture Substances 0.000 title description 14
• 230000014509 gene expression Effects 0.000 claims description 147
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 134
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 134
• 208000023105 Huntington disease Diseases 0.000 claims description 134
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 claims description 131
• 239000008194 pharmaceutical composition Substances 0.000 claims description 103
• 210000002569 neuron Anatomy 0.000 claims description 84
• 238000003306 harvesting Methods 0.000 claims description 72
• 230000004770 neurodegeneration Effects 0.000 claims description 49
• 238000001990 intravenous administration Methods 0.000 claims description 37
• 208000018737 Parkinson disease Diseases 0.000 claims description 33
• 102100024556 Protein phosphatase 1 regulatory subunit 1B Human genes 0.000 claims description 33
• 238000011282 treatment Methods 0.000 claims description 33
• 102100032912 CD44 antigen Human genes 0.000 claims description 31
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 31
• 230000008499 blood brain barrier function Effects 0.000 claims description 31
• 210000001218 blood-brain barrier Anatomy 0.000 claims description 31
• 208000024827 Alzheimer disease Diseases 0.000 claims description 29
• 238000007910 systemic administration Methods 0.000 claims description 26
• 238000002347 injection Methods 0.000 claims description 24
• 239000007924 injection Substances 0.000 claims description 24
• 102100022749 Aminopeptidase N Human genes 0.000 claims description 23
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims description 22
• 210000003169 central nervous system Anatomy 0.000 claims description 22
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 19
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 19
• 230000001965 increasing effect Effects 0.000 claims description 19
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 18
• 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 claims description 17
• 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 claims description 17
• 208000006011 Stroke Diseases 0.000 claims description 14
• 230000000735 allogeneic effect Effects 0.000 claims description 14
• 108050006871 Protein phosphatase 1 regulatory subunit 1B Proteins 0.000 claims description 11
• 201000006417 multiple sclerosis Diseases 0.000 claims description 11
• 206010010904 Convulsion Diseases 0.000 claims description 9
• 208000019430 Motor disease Diseases 0.000 claims description 9
• 208000028867 ischemia Diseases 0.000 claims description 9
• 230000001105 regulatory effect Effects 0.000 claims description 9
• 206010003805 Autism Diseases 0.000 claims description 8
• 208000020706 Autistic disease Diseases 0.000 claims description 8
• 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 8
• 230000001363 autoimmune Effects 0.000 claims description 8
• 201000002491 encephalomyelitis Diseases 0.000 claims description 8
• 201000001119 neuropathy Diseases 0.000 claims description 8
• 230000007823 neuropathy Effects 0.000 claims description 8
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 8
• 230000008439 repair process Effects 0.000 claims description 8
• 201000000980 schizophrenia Diseases 0.000 claims description 8
• 102100020756 D(2) dopamine receptor Human genes 0.000 claims description 7
• 101000931901 Homo sapiens D(2) dopamine receptor Proteins 0.000 claims description 7
• 210000002865 immune cell Anatomy 0.000 claims description 7
• 210000005064 dopaminergic neuron Anatomy 0.000 claims description 5
• 230000002519 immonomodulatory effect Effects 0.000 claims description 4
• 238000007912 intraperitoneal administration Methods 0.000 claims description 4
• 230000010261 cell growth Effects 0.000 claims description 3
• 239000003076 neurotropic agent Substances 0.000 claims description 2
• 230000001737 promoting effect Effects 0.000 claims description 2
• 102000007982 Phosphoproteins Human genes 0.000 claims 7
• 108010089430 Phosphoproteins Proteins 0.000 claims 7
• 210000004027 cell Anatomy 0.000 description 358
• 210000000130 stem cell Anatomy 0.000 description 230
• 241001465754 Metazoa Species 0.000 description 103
• 210000003074 dental pulp Anatomy 0.000 description 103
• 238000000034 method Methods 0.000 description 98
• WBLZUCOIBUDNBV-UHFFFAOYSA-N 3-nitropropanoic acid Chemical compound OC(=O)CC[N+]([O-])=O WBLZUCOIBUDNBV-UHFFFAOYSA-N 0.000 description 92
• 210000004556 brain Anatomy 0.000 description 86
• 238000002054 transplantation Methods 0.000 description 69
• 210000001519 tissue Anatomy 0.000 description 67
• 241000700159 Rattus Species 0.000 description 64
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 59
• 210000001577 neostriatum Anatomy 0.000 description 59
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 53
• 239000003550 marker Substances 0.000 description 47
• 108090000623 proteins and genes Proteins 0.000 description 46
• 210000003414 extremity Anatomy 0.000 description 40
• 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 38
• 101710176164 Broad substrate specificity ATP-binding cassette transporter ABCG2 Proteins 0.000 description 37
• 206010033885 Paraparesis Diseases 0.000 description 37
• 206010043276 Teratoma Diseases 0.000 description 36
• 230000004069 differentiation Effects 0.000 description 36
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 33
• 230000034994 death Effects 0.000 description 33
• 231100000517 death Toxicity 0.000 description 33
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
• 206010003591 Ataxia Diseases 0.000 description 31
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 31
• 238000004458 analytical method Methods 0.000 description 30
• 210000000933 neural crest Anatomy 0.000 description 30
• 102000004169 proteins and genes Human genes 0.000 description 30
• 108010025020 Nerve Growth Factor Proteins 0.000 description 29
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 27
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 27
• 239000001963 growth medium Substances 0.000 description 27
• 210000005155 neural progenitor cell Anatomy 0.000 description 27
• 230000004766 neurogenesis Effects 0.000 description 27
• 102000005962 receptors Human genes 0.000 description 27
• 108020003175 receptors Proteins 0.000 description 27
• 201000010099 disease Diseases 0.000 description 26
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 25
• 238000004519 manufacturing process Methods 0.000 description 25
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 24
• 210000003141 lower extremity Anatomy 0.000 description 24
• 239000002953 phosphate buffered saline Substances 0.000 description 24
• 238000012360 testing method Methods 0.000 description 24
• 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 23
• 102100024270 Transcription factor SOX-2 Human genes 0.000 description 23
• 230000006698 induction Effects 0.000 description 23
• 239000002609 medium Substances 0.000 description 23
• 208000015122 neurodegenerative disease Diseases 0.000 description 23
• 101100520968 Homo sapiens PPP1R1B gene Proteins 0.000 description 22
• 230000000694 effects Effects 0.000 description 22
• 230000008569 process Effects 0.000 description 22
• 230000015572 biosynthetic process Effects 0.000 description 21
• 102100038313 Transcription factor E2-alpha Human genes 0.000 description 20
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 20
• 230000000926 neurological effect Effects 0.000 description 20
• 241000699666 Mus <mouse, genus> Species 0.000 description 19
• 230000037396 body weight Effects 0.000 description 19
• 238000000338 in vitro Methods 0.000 description 19
• 241000699670 Mus sp. Species 0.000 description 18
• 208000007542 Paresis Diseases 0.000 description 18
• 238000011161 development Methods 0.000 description 18
• 230000018109 developmental process Effects 0.000 description 18
• 206010061218 Inflammation Diseases 0.000 description 17
• 238000002659 cell therapy Methods 0.000 description 16
• 230000004054 inflammatory process Effects 0.000 description 16
• 230000007246 mechanism Effects 0.000 description 16
• 102100022464 5'-nucleotidase Human genes 0.000 description 15
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 15
• 102000007072 Nerve Growth Factors Human genes 0.000 description 15
• 229960003638 dopamine Drugs 0.000 description 15
• 210000004498 neuroglial cell Anatomy 0.000 description 15
• 210000000056 organ Anatomy 0.000 description 15
• 102000015336 Nerve Growth Factor Human genes 0.000 description 14
• 210000001691 amnion Anatomy 0.000 description 14
• 229940053128 nerve growth factor Drugs 0.000 description 14
• 230000028327 secretion Effects 0.000 description 14
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 14
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 13
• 238000003556 assay Methods 0.000 description 13
• 210000004369 blood Anatomy 0.000 description 13
• 239000008280 blood Substances 0.000 description 13
• 239000002771 cell marker Substances 0.000 description 13
• 238000012744 immunostaining Methods 0.000 description 13
• 238000000386 microscopy Methods 0.000 description 13
• 239000000047 product Substances 0.000 description 13
• 210000005013 brain tissue Anatomy 0.000 description 12
• 239000003814 drug Substances 0.000 description 12
• 238000002955 isolation Methods 0.000 description 12
• 230000003902 lesion Effects 0.000 description 12
• 230000004112 neuroprotection Effects 0.000 description 12
• 230000000324 neuroprotective effect Effects 0.000 description 12
• 238000002560 therapeutic procedure Methods 0.000 description 12
• 206010028980 Neoplasm Diseases 0.000 description 11
• 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 11
• 210000001130 astrocyte Anatomy 0.000 description 11
• 210000001185 bone marrow Anatomy 0.000 description 11
• 210000000987 immune system Anatomy 0.000 description 11
• 238000003364 immunohistochemistry Methods 0.000 description 11
• -1 inactive nanog Proteins 0.000 description 11
• 230000001939 inductive effect Effects 0.000 description 11
• 238000010253 intravenous injection Methods 0.000 description 11
• 230000005012 migration Effects 0.000 description 11
• 238000013508 migration Methods 0.000 description 11
• 239000003900 neurotrophic factor Substances 0.000 description 11
• 210000003668 pericyte Anatomy 0.000 description 11
• 239000012071 phase Substances 0.000 description 11
• 208000024891 symptom Diseases 0.000 description 11
• 230000001225 therapeutic effect Effects 0.000 description 11
• 238000012546 transfer Methods 0.000 description 11
• 108010088225 Nestin Proteins 0.000 description 10
• 102000008730 Nestin Human genes 0.000 description 10
• 238000010171 animal model Methods 0.000 description 10
• 238000013459 approach Methods 0.000 description 10
• 210000001671 embryonic stem cell Anatomy 0.000 description 10
• 239000012091 fetal bovine serum Substances 0.000 description 10
• 210000000274 microglia Anatomy 0.000 description 10
• 210000005055 nestin Anatomy 0.000 description 10
• 238000011084 recovery Methods 0.000 description 10
• 239000011780 sodium chloride Substances 0.000 description 10
• 102000004127 Cytokines Human genes 0.000 description 9
• 108090000695 Cytokines Proteins 0.000 description 9
• 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 9
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 9
• 210000000988 bone and bone Anatomy 0.000 description 9
• 210000004489 deciduous teeth Anatomy 0.000 description 9
• 238000002474 experimental method Methods 0.000 description 9
• 210000002950 fibroblast Anatomy 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 230000012010 growth Effects 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 230000004807 localization Effects 0.000 description 9
• 238000010172 mouse model Methods 0.000 description 9
• 230000007170 pathology Effects 0.000 description 9
• 229920003023 plastic Polymers 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• 238000009168 stem cell therapy Methods 0.000 description 9
• 238000009580 stem-cell therapy Methods 0.000 description 9
• 230000004083 survival effect Effects 0.000 description 9
• 230000009885 systemic effect Effects 0.000 description 9
• 208000016261 weight loss Diseases 0.000 description 9
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 8
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 8
• 241000282472 Canis lupus familiaris Species 0.000 description 8
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
• 102100037241 Endoglin Human genes 0.000 description 8
• 102100025759 Keratin, type II cytoskeletal 3 Human genes 0.000 description 8
• 108010070918 Keratin-3 Proteins 0.000 description 8
• 241000204031 Mycoplasma Species 0.000 description 8
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 8
• 210000004204 blood vessel Anatomy 0.000 description 8
• 238000004113 cell culture Methods 0.000 description 8
• 230000001413 cellular effect Effects 0.000 description 8
• 238000005138 cryopreservation Methods 0.000 description 8
• 230000006378 damage Effects 0.000 description 8
• 238000001514 detection method Methods 0.000 description 8
• 210000001320 hippocampus Anatomy 0.000 description 8
• 238000012423 maintenance Methods 0.000 description 8
• 230000000877 morphologic effect Effects 0.000 description 8
• 210000001178 neural stem cell Anatomy 0.000 description 8
• 210000001778 pluripotent stem cell Anatomy 0.000 description 8
• 230000003248 secreting effect Effects 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 108010090047 Dopamine and cAMP-Regulated Phosphoprotein 32 Proteins 0.000 description 7
• 102000012749 Dopamine and cAMP-Regulated Phosphoprotein 32 Human genes 0.000 description 7
• 102000009024 Epidermal Growth Factor Human genes 0.000 description 7
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 7
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 7
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 7
• 101000881679 Homo sapiens Endoglin Proteins 0.000 description 7
• 102100023967 Keratin, type I cytoskeletal 12 Human genes 0.000 description 7
• 108010065086 Keratin-12 Proteins 0.000 description 7
• 206010024264 Lethargy Diseases 0.000 description 7
• 230000004913 activation Effects 0.000 description 7
• 239000000427 antigen Substances 0.000 description 7
• 108091007433 antigens Proteins 0.000 description 7
• 102000036639 antigens Human genes 0.000 description 7
• 230000004888 barrier function Effects 0.000 description 7
• 238000012258 culturing Methods 0.000 description 7
• 230000006735 deficit Effects 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• 210000002744 extracellular matrix Anatomy 0.000 description 7
• 230000001605 fetal effect Effects 0.000 description 7
• 230000002518 glial effect Effects 0.000 description 7
• 239000002858 neurotransmitter agent Substances 0.000 description 7
• 239000002243 precursor Substances 0.000 description 7
• 238000011552 rat model Methods 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 229960005322 streptomycin Drugs 0.000 description 7
• 238000012384 transportation and delivery Methods 0.000 description 7
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 6
• 238000010826 Nissl staining Methods 0.000 description 6
• 102000013127 Vimentin Human genes 0.000 description 6
• 108010065472 Vimentin Proteins 0.000 description 6
• 230000009471 action Effects 0.000 description 6
• 210000000577 adipose tissue Anatomy 0.000 description 6
• 210000004504 adult stem cell Anatomy 0.000 description 6
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 238000012512 characterization method Methods 0.000 description 6
• 210000001653 corpus striatum Anatomy 0.000 description 6
• 210000000805 cytoplasm Anatomy 0.000 description 6
• 230000003511 endothelial effect Effects 0.000 description 6
• 238000000684 flow cytometry Methods 0.000 description 6
• 230000002068 genetic effect Effects 0.000 description 6
• 230000002757 inflammatory effect Effects 0.000 description 6
• 210000000265 leukocyte Anatomy 0.000 description 6
• 210000004185 liver Anatomy 0.000 description 6
• 230000003287 optical effect Effects 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 6
• 210000005048 vimentin Anatomy 0.000 description 6
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 5
• 101150000157 ARHGEF1 gene Proteins 0.000 description 5
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 5
• 108010036949 Cyclosporine Proteins 0.000 description 5
• 102000053171 Glial Fibrillary Acidic Human genes 0.000 description 5
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 229930182555 Penicillin Natural products 0.000 description 5
• 210000001744 T-lymphocyte Anatomy 0.000 description 5
• 230000005856 abnormality Effects 0.000 description 5
• 230000006399 behavior Effects 0.000 description 5
• 230000033228 biological regulation Effects 0.000 description 5
• 239000011575 calcium Substances 0.000 description 5
• 229910052791 calcium Inorganic materials 0.000 description 5
• 238000006243 chemical reaction Methods 0.000 description 5
• 230000006866 deterioration Effects 0.000 description 5
• 206010015037 epilepsy Diseases 0.000 description 5
• 238000011156 evaluation Methods 0.000 description 5
• 210000003194 forelimb Anatomy 0.000 description 5
• 230000005021 gait Effects 0.000 description 5
• 210000001654 germ layer Anatomy 0.000 description 5
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 5
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 5
• 208000014674 injury Diseases 0.000 description 5
• 238000000506 liquid--solid chromatography Methods 0.000 description 5
• 230000007774 longterm Effects 0.000 description 5
• 101150055452 lsc gene Proteins 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 230000004031 neuronal differentiation Effects 0.000 description 5
• 230000000508 neurotrophic effect Effects 0.000 description 5
• 229940049954 penicillin Drugs 0.000 description 5
• 231100000331 toxic Toxicity 0.000 description 5
• 230000002588 toxic effect Effects 0.000 description 5
• 230000005740 tumor formation Effects 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 230000004580 weight loss Effects 0.000 description 5
• 241000283690 Bos taurus Species 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• 241000712083 Canine morbillivirus Species 0.000 description 4
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 4
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 4
• 229930105110 Cyclosporin A Natural products 0.000 description 4
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 4
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 4
• 101000976622 Homo sapiens Zinc finger protein 42 homolog Proteins 0.000 description 4
• 206010062016 Immunosuppression Diseases 0.000 description 4
• 101000976618 Mus musculus Zinc finger protein 42 Proteins 0.000 description 4
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 4
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 4
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 4
• 238000011579 SCID mouse model Methods 0.000 description 4
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 4
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 4
• 208000027418 Wounds and injury Diseases 0.000 description 4
• 102100023550 Zinc finger protein 42 homolog Human genes 0.000 description 4
• 230000003110 anti-inflammatory effect Effects 0.000 description 4
• 210000003050 axon Anatomy 0.000 description 4
• 239000000090 biomarker Substances 0.000 description 4
• 230000024245 cell differentiation Effects 0.000 description 4
• 210000003710 cerebral cortex Anatomy 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 230000007850 degeneration Effects 0.000 description 4
• 230000008482 dysregulation Effects 0.000 description 4
• 238000006911 enzymatic reaction Methods 0.000 description 4
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 4
• 230000003325 follicular Effects 0.000 description 4
• 238000007710 freezing Methods 0.000 description 4
• 230000008014 freezing Effects 0.000 description 4
• 210000001222 gaba-ergic neuron Anatomy 0.000 description 4
• 230000003371 gabaergic effect Effects 0.000 description 4
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
• 230000005847 immunogenicity Effects 0.000 description 4
• 230000002480 immunoprotective effect Effects 0.000 description 4
• 230000001506 immunosuppresive effect Effects 0.000 description 4
• 238000007913 intrathecal administration Methods 0.000 description 4
• 210000003734 kidney Anatomy 0.000 description 4
• 108010082117 matrigel Proteins 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 210000003061 neural cell Anatomy 0.000 description 4
• 230000003959 neuroinflammation Effects 0.000 description 4
• 230000008506 pathogenesis Effects 0.000 description 4
• 230000003252 repetitive effect Effects 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 230000011664 signaling Effects 0.000 description 4
• 210000000952 spleen Anatomy 0.000 description 4
• 230000002269 spontaneous effect Effects 0.000 description 4
• 238000011476 stem cell transplantation Methods 0.000 description 4
• 230000001988 toxicity Effects 0.000 description 4
• 231100000419 toxicity Toxicity 0.000 description 4
• 230000032258 transport Effects 0.000 description 4
• 230000001228 trophic effect Effects 0.000 description 4
• 206010003694 Atrophy Diseases 0.000 description 3
• 108020004414 DNA Proteins 0.000 description 3
• 101150049660 DRD2 gene Proteins 0.000 description 3
• 206010061818 Disease progression Diseases 0.000 description 3
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 3
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 3
• 102000004889 Interleukin-6 Human genes 0.000 description 3
• 108090001005 Interleukin-6 Proteins 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• 229930182816 L-glutamine Natural products 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 3
• 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 3
• 102000013013 Member 2 Subfamily G ATP Binding Cassette Transporter Human genes 0.000 description 3
• 208000036110 Neuroinflammatory disease Diseases 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 229930040373 Paraformaldehyde Natural products 0.000 description 3
• 101800000645 Rhomboid-related protein 2, N-terminal fragment Proteins 0.000 description 3
• 102400000267 Rhomboid-related protein 2, N-terminal fragment Human genes 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• 102000019259 Succinate Dehydrogenase Human genes 0.000 description 3
• 108010012901 Succinate Dehydrogenase Proteins 0.000 description 3
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
• 101800000716 Tumor necrosis factor, membrane form Proteins 0.000 description 3
• 239000011717 all-trans-retinol Substances 0.000 description 3
• 235000019169 all-trans-retinol Nutrition 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940088710 antibiotic agent Drugs 0.000 description 3
• 230000037444 atrophy Effects 0.000 description 3
• 229940058140 avita Drugs 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 208000029028 brain injury Diseases 0.000 description 3
• 210000000845 cartilage Anatomy 0.000 description 3
• 230000012292 cell migration Effects 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 239000006285 cell suspension Substances 0.000 description 3
• 208000037976 chronic inflammation Diseases 0.000 description 3
• 230000006020 chronic inflammation Effects 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 238000011109 contamination Methods 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 238000009795 derivation Methods 0.000 description 3
• 230000005750 disease progression Effects 0.000 description 3
• 229940126534 drug product Drugs 0.000 description 3
• 210000002889 endothelial cell Anatomy 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 230000006862 enzymatic digestion Effects 0.000 description 3
• 238000013401 experimental design Methods 0.000 description 3
• 210000000604 fetal stem cell Anatomy 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000003102 growth factor Substances 0.000 description 3
• 229940077456 human brain-derived neurotrophic factor Drugs 0.000 description 3
• 238000003384 imaging method Methods 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 238000002991 immunohistochemical analysis Methods 0.000 description 3
• 238000013394 immunophenotyping Methods 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 230000036512 infertility Effects 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 238000000185 intracerebroventricular administration Methods 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 239000011777 magnesium Substances 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 230000015654 memory Effects 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 238000012544 monitoring process Methods 0.000 description 3
• 230000003562 morphometric effect Effects 0.000 description 3
• 238000013425 morphometry Methods 0.000 description 3
• 230000016273 neuron death Effects 0.000 description 3
• 230000007514 neuronal growth Effects 0.000 description 3
• 230000006576 neuronal survival Effects 0.000 description 3
• 230000035771 neuroregeneration Effects 0.000 description 3
• 230000003076 paracrine Effects 0.000 description 3
• 229920002866 paraformaldehyde Polymers 0.000 description 3
• 210000001428 peripheral nervous system Anatomy 0.000 description 3
• 239000000825 pharmaceutical preparation Substances 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 230000000770 proinflammatory effect Effects 0.000 description 3
• 210000002637 putamen Anatomy 0.000 description 3
• 230000008929 regeneration Effects 0.000 description 3
• 238000011069 regeneration method Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 210000000278 spinal cord Anatomy 0.000 description 3
• 210000000603 stem cell niche Anatomy 0.000 description 3
• 239000008174 sterile solution Substances 0.000 description 3
• 210000003523 substantia nigra Anatomy 0.000 description 3
• 230000017423 tissue regeneration Effects 0.000 description 3
• 239000003656 tris buffered saline Substances 0.000 description 3
• 210000003954 umbilical cord Anatomy 0.000 description 3
• 230000003827 upregulation Effects 0.000 description 3
• 210000003462 vein Anatomy 0.000 description 3
• 230000035899 viability Effects 0.000 description 3
• PJOHVEQSYPOERL-SHEAVXILSA-N (e)-n-[(4r,4as,7ar,12br)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-methylphenyl)prop-2-enamide Chemical compound C1=CC(C)=CC=C1\C=C\C(=O)N[C@]1(CCC(=O)[C@@H]2O3)[C@H]4CC5=CC=C(O)C3=C5[C@]12CCN4CC1CC1 PJOHVEQSYPOERL-SHEAVXILSA-N 0.000 description 2
• KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 2
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 2
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 2
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 2
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000271566 Aves Species 0.000 description 2
• 101001011741 Bos taurus Insulin Proteins 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
• 108010074051 C-Reactive Protein Proteins 0.000 description 2
• 102100032752 C-reactive protein Human genes 0.000 description 2
• 108010052495 Calgranulin B Proteins 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
• 208000028698 Cognitive impairment Diseases 0.000 description 2
• 108010035532 Collagen Proteins 0.000 description 2
• 102000008186 Collagen Human genes 0.000 description 2
• 206010010947 Coordination abnormal Diseases 0.000 description 2
• 208000016192 Demyelinating disease Diseases 0.000 description 2
• 206010012305 Demyelination Diseases 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 229930182566 Gentamicin Natural products 0.000 description 2
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 2
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 2
• 101000739876 Homo sapiens Brain-derived neurotrophic factor Proteins 0.000 description 2
• 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 2
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
• 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
• 101000929663 Homo sapiens Phospholipid-transporting ATPase ABCA7 Proteins 0.000 description 2
• 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 2
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
• 206010061296 Motor dysfunction Diseases 0.000 description 2
• 102100022691 NACHT, LRR and PYD domains-containing protein 3 Human genes 0.000 description 2
• 102100023055 Neurofilament medium polypeptide Human genes 0.000 description 2
• 108090000189 Neuropeptides Proteins 0.000 description 2
• 206010033799 Paralysis Diseases 0.000 description 2
• 239000004107 Penicillin G sodium Substances 0.000 description 2
• 102100036620 Phospholipid-transporting ATPase ABCA7 Human genes 0.000 description 2
• 208000010366 Postpoliomyelitis syndrome Diseases 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 108010001946 Pyrin Domain-Containing 3 Protein NLR Family Proteins 0.000 description 2
• 108090000184 Selectins Proteins 0.000 description 2
• 102000003800 Selectins Human genes 0.000 description 2
• 206010043275 Teratogenicity Diseases 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 230000035508 accumulation Effects 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000008186 active pharmaceutical agent Substances 0.000 description 2
• 210000001789 adipocyte Anatomy 0.000 description 2
• 230000032683 aging Effects 0.000 description 2
• 210000001643 allantois Anatomy 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 238000004873 anchoring Methods 0.000 description 2
• 230000033115 angiogenesis Effects 0.000 description 2
• 230000002491 angiogenic effect Effects 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 210000004227 basal ganglia Anatomy 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000003542 behavioural effect Effects 0.000 description 2
• 230000000975 bioactive effect Effects 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 2
• 210000004781 brain capillary Anatomy 0.000 description 2
• 210000004958 brain cell Anatomy 0.000 description 2
• 201000008247 brain infarction Diseases 0.000 description 2
• 208000025698 brain inflammatory disease Diseases 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 230000030570 cellular localization Effects 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 210000001612 chondrocyte Anatomy 0.000 description 2
• 230000008045 co-localization Effects 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 208000010877 cognitive disease Diseases 0.000 description 2
• 229920001436 collagen Polymers 0.000 description 2
• 230000001332 colony forming effect Effects 0.000 description 2
• 238000004624 confocal microscopy Methods 0.000 description 2
• 230000008021 deposition Effects 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 229940088679 drug related substance Drugs 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 210000004700 fetal blood Anatomy 0.000 description 2
• 239000012894 fetal calf serum Substances 0.000 description 2
• 239000013020 final formulation Substances 0.000 description 2
• 239000012595 freezing medium Substances 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 102000051542 human BDNF Human genes 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 229960000890 hydrocortisone Drugs 0.000 description 2
• 230000005934 immune activation Effects 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 230000002055 immunohistochemical effect Effects 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 208000016290 incoordination Diseases 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 238000011081 inoculation Methods 0.000 description 2
• 238000007689 inspection Methods 0.000 description 2
• 210000004692 intercellular junction Anatomy 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• 230000009545 invasion Effects 0.000 description 2
• 230000000302 ischemic effect Effects 0.000 description 2
• 210000001161 mammalian embryo Anatomy 0.000 description 2
• 230000035800 maturation Effects 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 230000002025 microglial effect Effects 0.000 description 2
• 230000002438 mitochondrial effect Effects 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004660 morphological change Effects 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 210000000653 nervous system Anatomy 0.000 description 2
• 210000003757 neuroblast Anatomy 0.000 description 2
• 230000007472 neurodevelopment Effects 0.000 description 2
• 230000030648 nucleus localization Effects 0.000 description 2
• 210000004248 oligodendroglia Anatomy 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 210000000963 osteoblast Anatomy 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000012188 paraffin wax Substances 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 235000019369 penicillin G sodium Nutrition 0.000 description 2
• 229940056360 penicillin g Drugs 0.000 description 2
• 230000003239 periodontal effect Effects 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 230000035699 permeability Effects 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000001817 pituitary effect Effects 0.000 description 2
• 239000000902 placebo Substances 0.000 description 2
• 229940068196 placebo Drugs 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 238000004321 preservation Methods 0.000 description 2
• 238000009117 preventive therapy Methods 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 230000002062 proliferating effect Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 208000020016 psychiatric disease Diseases 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 239000002994 raw material Substances 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000001172 regenerating effect Effects 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 238000011808 rodent model Methods 0.000 description 2
• 238000013341 scale-up Methods 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 210000002460 smooth muscle Anatomy 0.000 description 2
• 208000020431 spinal cord injury Diseases 0.000 description 2
• 208000002320 spinal muscular atrophy Diseases 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 238000002660 stem cell treatment Methods 0.000 description 2
• 239000003270 steroid hormone Substances 0.000 description 2
• 210000002536 stromal cell Anatomy 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 230000003976 synaptic dysfunction Effects 0.000 description 2
• 231100000211 teratogenicity Toxicity 0.000 description 2
• 210000001103 thalamus Anatomy 0.000 description 2
• 238000010257 thawing Methods 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 210000001364 upper extremity Anatomy 0.000 description 2
• 238000005303 weighing Methods 0.000 description 2
• 210000001325 yolk sac Anatomy 0.000 description 2
• OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 108010022794 2',3'-Cyclic-Nucleotide Phosphodiesterases Proteins 0.000 description 1
• 102100040458 2',3'-cyclic-nucleotide 3'-phosphodiesterase Human genes 0.000 description 1
• WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
• QZDDFQLIQRYMBV-UHFFFAOYSA-N 2-[3-nitro-2-(2-nitrophenyl)-4-oxochromen-8-yl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(C=2[N+]([O-])=O)=O)=C1OC=2C1=CC=CC=C1[N+]([O-])=O QZDDFQLIQRYMBV-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• PTYVBEKOPJHZLJ-UHFFFAOYSA-N 2-nitropropanoic acid Chemical compound OC(=O)C(C)[N+]([O-])=O PTYVBEKOPJHZLJ-UHFFFAOYSA-N 0.000 description 1
• 101150007658 ABCG3 gene Proteins 0.000 description 1
• ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
• 102100026882 Alpha-synuclein Human genes 0.000 description 1
• 238000010173 Alzheimer-disease mouse model Methods 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
• 208000037259 Amyloid Plaque Diseases 0.000 description 1
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
• 101150035467 BDNF gene Proteins 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
• 101000766308 Bos taurus Serotransferrin Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 102100021984 C-C motif chemokine 4-like Human genes 0.000 description 1
• 108010049990 CD13 Antigens Proteins 0.000 description 1
• 102000018755 Calgranulin B Human genes 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108010055165 Chemokine CCL4 Proteins 0.000 description 1
• 102000009016 Cholera Toxin Human genes 0.000 description 1
• 108010049048 Cholera Toxin Proteins 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 208000031404 Chromosome Aberrations Diseases 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 241001573498 Compacta Species 0.000 description 1
• 206010011953 Decreased activity Diseases 0.000 description 1
• 208000019505 Deglutition disease Diseases 0.000 description 1
• 206010012239 Delusion Diseases 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 206010054089 Depressive symptom Diseases 0.000 description 1
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
• 241001269524 Dura Species 0.000 description 1
• 206010013887 Dysarthria Diseases 0.000 description 1
• 208000012661 Dyskinesia Diseases 0.000 description 1
• 208000014094 Dystonic disease Diseases 0.000 description 1
• 238000008157 ELISA kit Methods 0.000 description 1
• 241000876833 Emberizinae Species 0.000 description 1
• 108010036395 Endoglin Proteins 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 241000272496 Galliformes Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 1
• 241000293495 Glia Species 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 239000007756 Ham's F12 Nutrient Mixture Substances 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 description 1
• 229920002971 Heparan sulfate Polymers 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 101000823298 Homo sapiens Broad substrate specificity ATP-binding cassette transporter ABCG2 Proteins 0.000 description 1
• 101001030705 Homo sapiens Huntingtin Proteins 0.000 description 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 1
• 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
• 101000979321 Homo sapiens Neurofilament medium polypeptide Proteins 0.000 description 1
• 101001109800 Homo sapiens Pro-neuregulin-1, membrane-bound isoform Proteins 0.000 description 1
• 101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 description 1
• 101000980827 Homo sapiens T-cell surface glycoprotein CD1a Proteins 0.000 description 1
• 101000716149 Homo sapiens T-cell surface glycoprotein CD1b Proteins 0.000 description 1
• 101000716124 Homo sapiens T-cell surface glycoprotein CD1c Proteins 0.000 description 1
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 102100038562 Huntingtin Human genes 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 102100025304 Integrin beta-1 Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 208000015592 Involuntary movements Diseases 0.000 description 1
• 239000002211 L-ascorbic acid Substances 0.000 description 1
• 235000000069 L-ascorbic acid Nutrition 0.000 description 1
• 108010085895 Laminin Proteins 0.000 description 1
• 102000007547 Laminin Human genes 0.000 description 1
• 102100039564 Leukosialin Human genes 0.000 description 1
• 206010072138 Limbal stem cell deficiency Diseases 0.000 description 1
• 101150066553 MDR1 gene Proteins 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 208000024556 Mendelian disease Diseases 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 208000002740 Muscle Rigidity Diseases 0.000 description 1
• 102000002247 NADPH Dehydrogenase Human genes 0.000 description 1
• 108010014870 NADPH Dehydrogenase Proteins 0.000 description 1
• 229920002274 Nalgene Polymers 0.000 description 1
• 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 description 1
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
• 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
• 206010029350 Neurotoxicity Diseases 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 101150056950 Ntrk2 gene Proteins 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 206010031264 Osteonecrosis Diseases 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 102100032420 Protein S100-A9 Human genes 0.000 description 1
• 102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 101001030728 Rattus norvegicus Huntingtin Proteins 0.000 description 1
• 208000014151 Stomatognathic disease Diseases 0.000 description 1
• 108010091128 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
• 102000018066 Subfamily G ATP Binding Cassette Transporter Human genes 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 108090000054 Syndecan-2 Proteins 0.000 description 1
• 102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 1
• 208000000323 Tourette Syndrome Diseases 0.000 description 1
• 208000016620 Tourette disease Diseases 0.000 description 1
• 206010044221 Toxic encephalopathy Diseases 0.000 description 1
• 241000589884 Treponema pallidum Species 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 102100035140 Vitronectin Human genes 0.000 description 1
• ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000009056 active transport Effects 0.000 description 1
• 230000009692 acute damage Effects 0.000 description 1
• 230000033289 adaptive immune response Effects 0.000 description 1
• 230000004721 adaptive immunity Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 108090000185 alpha-Synuclein Proteins 0.000 description 1
• WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 229960003942 amphotericin b Drugs 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 210000004727 amygdala Anatomy 0.000 description 1
• 230000002547 anomalous effect Effects 0.000 description 1
• 230000001772 anti-angiogenic effect Effects 0.000 description 1
• 230000002424 anti-apoptotic effect Effects 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 108010054176 apotransferrin Proteins 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 230000003140 astrocytic effect Effects 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 230000028600 axonogenesis Effects 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 239000012888 bovine serum Substances 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000013590 bulk material Substances 0.000 description 1
• 210000000748 cardiovascular system Anatomy 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 210000001159 caudate nucleus Anatomy 0.000 description 1
• 230000000453 cell autonomous effect Effects 0.000 description 1
• 230000008568 cell cell communication Effects 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000006721 cell death pathway Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000006727 cell loss Effects 0.000 description 1
• 230000007248 cellular mechanism Effects 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 239000002975 chemoattractant Substances 0.000 description 1
• 230000003399 chemotactic effect Effects 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 230000001713 cholinergic effect Effects 0.000 description 1
• 210000002932 cholinergic neuron Anatomy 0.000 description 1
• 230000009816 chondrogenic differentiation Effects 0.000 description 1
• 208000012601 choreatic disease Diseases 0.000 description 1
• 231100000005 chromosome aberration Toxicity 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 230000003021 clonogenic effect Effects 0.000 description 1
• 239000011247 coating layer Substances 0.000 description 1
• 230000019771 cognition Effects 0.000 description 1
• 230000007278 cognition impairment Effects 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 230000005757 colony formation Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 230000007711 cytoplasmic localization Effects 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 231100000868 delusion Toxicity 0.000 description 1
• 208000002925 dental caries Diseases 0.000 description 1
• 210000001968 dental pulp cell Anatomy 0.000 description 1
• 210000001947 dentate gyrus Anatomy 0.000 description 1
• 210000004268 dentin Anatomy 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 230000007357 depressive behavior Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 230000003291 dopaminomimetic effect Effects 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 208000010118 dystonia Diseases 0.000 description 1
• 230000005584 early death Effects 0.000 description 1
• 230000007937 eating Effects 0.000 description 1
• 230000027721 electron transport chain Effects 0.000 description 1
• 210000002242 embryoid body Anatomy 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 210000003989 endothelium vascular Anatomy 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 230000037149 energy metabolism Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 230000001973 epigenetic effect Effects 0.000 description 1
• 230000008472 epithelial growth Effects 0.000 description 1
• 210000003560 epithelium corneal Anatomy 0.000 description 1
• 210000002304 esc Anatomy 0.000 description 1
• 231100000318 excitotoxic Toxicity 0.000 description 1
• 230000003492 excitotoxic effect Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000004299 exfoliation Methods 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 230000008713 feedback mechanism Effects 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 230000001408 fungistatic effect Effects 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 230000004022 gliogenesis Effects 0.000 description 1
• 239000001046 green dye Substances 0.000 description 1
• 101150113725 hd gene Proteins 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 230000005745 host immune response Effects 0.000 description 1
• 102000046949 human MSC Human genes 0.000 description 1
• 102000055650 human NRG1 Human genes 0.000 description 1
• 208000013403 hyperactivity Diseases 0.000 description 1
• 230000001660 hyperkinetic effect Effects 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 238000011532 immunohistochemical staining Methods 0.000 description 1
• 238000013388 immunohistochemistry analysis Methods 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 210000005007 innate immune system Anatomy 0.000 description 1
• 230000030214 innervation Effects 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 230000008316 intracellular mechanism Effects 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 239000013038 irreversible inhibitor Substances 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 238000011694 lewis rat Methods 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 231100000861 limb weakness Toxicity 0.000 description 1
• 208000027905 limb weakness Diseases 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 210000004373 mandible Anatomy 0.000 description 1
• 238000013411 master cell bank Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 210000002050 maxilla Anatomy 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000006984 memory degeneration Effects 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 210000004088 microvessel Anatomy 0.000 description 1
• 230000001617 migratory effect Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 230000004065 mitochondrial dysfunction Effects 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 210000002161 motor neuron Anatomy 0.000 description 1
• 239000012120 mounting media Substances 0.000 description 1
• 210000002894 multi-fate stem cell Anatomy 0.000 description 1
• 230000036457 multidrug resistance Effects 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 201000006938 muscular dystrophy Diseases 0.000 description 1
• 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 210000000651 myofibroblast Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000001982 neural crest cell Anatomy 0.000 description 1
• 210000002241 neurite Anatomy 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 210000000461 neuroepithelial cell Anatomy 0.000 description 1
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
• 230000001272 neurogenic effect Effects 0.000 description 1
• 210000003633 neuroglioblast Anatomy 0.000 description 1
• 230000007971 neurological deficit Effects 0.000 description 1
• 230000003955 neuronal function Effects 0.000 description 1
• 230000007996 neuronal plasticity Effects 0.000 description 1
• 230000009689 neuronal regeneration Effects 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 238000011859 neuroprotective therapy Methods 0.000 description 1
• 230000003018 neuroregenerative effect Effects 0.000 description 1
• 230000002887 neurotoxic effect Effects 0.000 description 1
• 231100000228 neurotoxicity Toxicity 0.000 description 1
• 230000007135 neurotoxicity Effects 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 230000007959 normoxia Effects 0.000 description 1
• 238000011580 nude mouse model Methods 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 101710135378 pH 6 antigen Proteins 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000004963 pathophysiological condition Effects 0.000 description 1
• 230000001991 pathophysiological effect Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000008447 perception Effects 0.000 description 1
• 208000033300 perinatal asphyxia Diseases 0.000 description 1
• 210000002379 periodontal ligament Anatomy 0.000 description 1
• 230000003836 peripheral circulation Effects 0.000 description 1
• 210000004786 perivascular cell Anatomy 0.000 description 1
• 230000008823 permeabilization Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 210000004694 pigment cell Anatomy 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 238000011176 pooling Methods 0.000 description 1
• 230000002980 postoperative effect Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 230000037457 pro-inflammatory mechanism Effects 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 201000002241 progressive bulbar palsy Diseases 0.000 description 1
• 210000001176 projection neuron Anatomy 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 230000009979 protective mechanism Effects 0.000 description 1
• 230000026447 protein localization Effects 0.000 description 1
• 238000003908 quality control method Methods 0.000 description 1
• GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
• 210000003124 radial glial cell Anatomy 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 208000012802 recumbency Diseases 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000008672 reprogramming Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 238000005096 rolling process Methods 0.000 description 1
• 238000011076 safety test Methods 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 230000036573 scar formation Effects 0.000 description 1
• 210000004116 schwann cell Anatomy 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 230000009476 short term action Effects 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 210000001626 skin fibroblast Anatomy 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 229960001471 sodium selenite Drugs 0.000 description 1
• 239000011781 sodium selenite Substances 0.000 description 1
• 235000015921 sodium selenite Nutrition 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 230000024642 stem cell division Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000005728 strengthening Methods 0.000 description 1
• 229960002385 streptomycin sulfate Drugs 0.000 description 1
• 230000002739 subcortical effect Effects 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000000153 supplemental effect Effects 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000003956 synaptic plasticity Effects 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 238000012385 systemic delivery Methods 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 230000007838 tissue remodeling Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
• 230000005748 tumor development Effects 0.000 description 1
• 210000005040 type I intermediate filament Anatomy 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 239000012808 vapor phase Substances 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000028973 vesicle-mediated transport Effects 0.000 description 1
• 230000007998 vessel formation Effects 0.000 description 1
• 210000003135 vibrissae Anatomy 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 210000004885 white matter Anatomy 0.000 description 1